Subscribe now

Comment and Health

Weight-loss injections need to be for life, not just two years

Health services need to plan around a growing number of people taking lifelong weight-loss injections such as Wegovy - and the sooner they face up to that, the better, says Clare Wilson

By Clare Wilson

9 August 2023

New Scientist Default Image

Simone Rotella

HEALTHCARE systems around the world are grappling with the arrival of a new kind of weight-loss treatment: injections based on the medicine semaglutide, which is branded as Wegovy or Ozempic.

The UK is among the first countries where semaglutide looks set to be made available for weight-loss treatment through a publicly funded health system. Unfortunately, many doctors think England’s guidance body has made a misstep by recommending people be restricted to two years of use, even though the drug is meant to be taken long-term. Health systems in other countries are also debating how to respond to this unprecedented situation,…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 28th October 2023.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account